Literature DB >> 10556203

CD137 induces proliferation and endomitosis in monocytes.

J Langstein1, J Michel, H Schwarz.   

Abstract

Peripheral monocytes are short-lived and are replenished from hematopoietic stem cells whose proliferation is believed to be confined to the bone marrow. Human peripheral monocytes are assumed not to be able to proliferate. In this study we show that CD137 (ILA/4-1BB), a member of the tumor necrosis factor receptor family, induces a widespread and profound proliferation of human peripheral monocytes. Macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor are essential, but not sufficient for proliferation. Additional soluble autocrine factors induced by CD137 are required. Induction of proliferation is mediated via reverse signaling through a CD137 ligand, expressed constitutively by peripheral monocytes. The ability of CD137 to induce proliferation in human peripheral monocytes is not shared by any other known molecule.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556203

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  Cross-linking of CD137 ligand modulates immune responses of thioglycollate-elicited mouse peritoneal macrophages.

Authors:  Jun-Sang Bae; Hyeong-Sup Kim; Jae Hong Park; Sang-Hyuk Park; Hyeon-Woo Lee
Journal:  Inflamm Res       Date:  2010-12-24       Impact factor: 4.575

2.  Regulation of mouse 4-1BB expression: multiple promoter usages and a splice variant.

Authors:  Jung D Kim; Chang H Kim; Byoung S Kwon
Journal:  Mol Cells       Date:  2011-01-11       Impact factor: 5.034

3.  CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer.

Authors:  Yingying Qian; Dong Pei; Ting Cheng; Changling Wu; Xiaolin Pu; Xiaofeng Chen; Yiqian Liu; Hong Shen; Weiwei Zhang; Yongqian Shu
Journal:  Med Oncol       Date:  2015-01-29       Impact factor: 3.064

Review 4.  CD137 and CD137L signals are main drivers of type 1, cell-mediated immune responses.

Authors:  Bhushan Dharmadhikari; Meihui Wu; Nur Sharalyn Abdullah; Sakthi Rajendran; Nur Diana Ishak; Emily Nickles; Zulkarnain Harfuddin; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2015-11-11       Impact factor: 8.110

5.  4-1BB ligand signaling to T cells limits T cell activation.

Authors:  So-Young Eun; Seung-Woo Lee; Yanfei Xu; Michael Croft
Journal:  J Immunol       Date:  2014-11-17       Impact factor: 5.422

6.  GeneChip analyses of global transcriptional responses of murine macrophages to the lethal toxin of Bacillus anthracis.

Authors:  Jason E Comer; Cristi L Galindo; Ashok K Chopra; Johnny W Peterson
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  CD137L-stimulated dendritic cells are more potent than conventional dendritic cells at eliciting cytotoxic T-cell responses.

Authors:  Zulkarnain Harfuddin; Shaqireen Kwajah; Adrian Chong Nyi Sim; Paul Anthony Macary; Herbert Schwarz
Journal:  Oncoimmunology       Date:  2013-11-11       Impact factor: 8.110

8.  Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling.

Authors:  Charles Gullo; Liang Kai Koh; Wan Lu Pang; Kian Tong Ho; Shi Hao Tan; Herbert Schwarz
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

9.  Fatty acids induce increased granulocyte macrophage-colony stimulating factor secretion through protein kinase C-activation in THP-1 macrophages.

Authors:  Nahid Bahramian; Gunnel Ostergren-Lundén; Göran Bondjers; Urban Olsson
Journal:  Lipids       Date:  2004-03       Impact factor: 1.880

Review 10.  Anti-CD137 antibodies in the treatment of autoimmune disease and cancer.

Authors:  Robert S Mittler; Juergen Foell; Megan McCausland; Simona Strahotin; Liguo Niu; Abhijit Bapat; L Becker Hewes
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.